Synopsis
Synopsis
0
JDMF
0
VMF
0
FDF
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
Annual Reports
NA
1. Dermofix
2. Dermoseptic
3. Ginedermofix
4. Mykosert
5. Sertaconazole
6. Sertaconazole Mononitrate
7. Zalain
1. 99592-39-9
2. Dermofix
3. Ertaczo
4. Zalain
5. Sertaconazole Mononitrate
6. Ginedermofix
7. Dermovit
8. Fi 7056
9. Sertaconazole (nitrate)
10. Fi-7045
11. 99592-39-9 (nitrate)
12. 1-[2-[(7-chloro-1-benzothiophen-3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl]imidazole;nitric Acid
13. 1dv05410m5
14. Fi-7056
15. 1-[2-[(7-chloro-1-benzothien-3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl]-1h-imidazole Nitrate
16. 1h-imidazole, 1-(2-((7-chlorobenzo(b)thien-3-yl)methoxy)-2-(2,4-dichlorophenyl)ethyl)-, Mononitrate
17. Dermoseptic
18. 1-{2-[(7-chloro-1-benzothiophen-3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl}-1h-imidazole; Nitric Acid
19. Fisderm
20. Extens
21. Onabet
22. Sr-05000001439
23. Unii-1dv05410m5
24. Sertaconazolenitrate
25. Ertaczo (tn)
26. Zalain (tn)
27. 1-(2-((7-chlorobenzo[b]thiophen-3-yl)methoxy)-2-(2,4-dichlorophenyl)ethyl)-1h-imidazole Nitrate
28. 1h-imidazole, 1-(2-((7-chlorobenzo(b)thien-3-yl)methoxy)-2-(2,4-dichlorophenyl)ethyl)-, Nitrate (1:1)
29. Ncgc00016966-01
30. Cas-99592-39-9
31. Dsstox_cid_25529
32. Dsstox_rid_80932
33. Dsstox_gsid_45529
34. Mls002154122
35. Schembl261807
36. Chembl1200725
37. Dtxsid2045529
38. Hy-b0736a
39. Hms1571a12
40. Hms2098a12
41. Hms2231n14
42. Hms3372h01
43. Hms3715a12
44. Sertaconazole Nitrate [mi]
45. Amy32537
46. Bcp09311
47. Tox21_110718
48. Ac-739
49. Fi7056
50. Mfcd00918063
51. S3161
52. Sertaconazole Nitrate [mart.]
53. Akos015888158
54. Akos015964610
55. Sertaconazole Nitrate [who-dd]
56. Ccg-221045
57. 1-[2-[(7-chloro-1-benzothiophen-3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl]imidazole; Nitric Acid
58. As-14332
59. Smr001233429
60. Sertaconazole Nitrate [orange Book]
61. Sertaconazole Nitrate [ep Monograph]
62. Ft-0674558
63. D08510
64. F20635
65. A846049
66. A851341
67. Sr-05000001439-3
68. Q27252298
69. 1-(2-((7-chlorobenzo(b)thien-3-yl)methoxy)-2-(2,4-dichlorophenyl)ethyl)-1h-imidazole Mononitrate
70. 1-[2-[(7-chloranyl-1-benzothiophen-3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl]imidazole; Nitric Acid
71. 1-[2-[(7-chloro-1-benzothiophen-3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl]imidazole,nitric Acid
1. Sertaconazole
2. Sertaconazol
3. Demofix
Molecular Weight | 500.8 g/mol |
---|---|
Molecular Formula | C20H16Cl3N3O4S |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 6 |
Exact Mass | 498.992710 g/mol |
Monoisotopic Mass | 498.992710 g/mol |
Topological Polar Surface Area | 121 Ų |
Heavy Atom Count | 31 |
Formal Charge | 0 |
Complexity | 513 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Ertaczo |
PubMed Health | Sertaconazole (On the skin) |
Drug Classes | Antifungal |
Drug Label | ERTACZO (sertaconazole nitrate) Cream, 2%, contains the imidazole antifungal, sertaconazole nitrate. Sertaconazole nitrate contains one asymmetric carbon atom and exists as a racemic mixture of equal amounts of R and S enantiomers.Sertaconazole nit... |
Active Ingredient | Sertaconazole nitrate |
Dosage Form | Cream |
Route | Topical |
Strength | 2% |
Market Status | Prescription |
Company | Valeant Luxembourg |
2 of 2 | |
---|---|
Drug Name | Ertaczo |
PubMed Health | Sertaconazole (On the skin) |
Drug Classes | Antifungal |
Drug Label | ERTACZO (sertaconazole nitrate) Cream, 2%, contains the imidazole antifungal, sertaconazole nitrate. Sertaconazole nitrate contains one asymmetric carbon atom and exists as a racemic mixture of equal amounts of R and S enantiomers.Sertaconazole nit... |
Active Ingredient | Sertaconazole nitrate |
Dosage Form | Cream |
Route | Topical |
Strength | 2% |
Market Status | Prescription |
Company | Valeant Luxembourg |
Antifungal Agents
Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Sertaconazole Nitrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sertaconazole Nitrate, including repackagers and relabelers. The FDA regulates Sertaconazole Nitrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sertaconazole Nitrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Sertaconazole Nitrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Sertaconazole Nitrate supplier is an individual or a company that provides Sertaconazole Nitrate active pharmaceutical ingredient (API) or Sertaconazole Nitrate finished formulations upon request. The Sertaconazole Nitrate suppliers may include Sertaconazole Nitrate API manufacturers, exporters, distributors and traders.
click here to find a list of Sertaconazole Nitrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Sertaconazole Nitrate DMF (Drug Master File) is a document detailing the whole manufacturing process of Sertaconazole Nitrate active pharmaceutical ingredient (API) in detail. Different forms of Sertaconazole Nitrate DMFs exist exist since differing nations have different regulations, such as Sertaconazole Nitrate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Sertaconazole Nitrate DMF submitted to regulatory agencies in the US is known as a USDMF. Sertaconazole Nitrate USDMF includes data on Sertaconazole Nitrate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Sertaconazole Nitrate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Sertaconazole Nitrate suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Sertaconazole Nitrate Drug Master File in Korea (Sertaconazole Nitrate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Sertaconazole Nitrate. The MFDS reviews the Sertaconazole Nitrate KDMF as part of the drug registration process and uses the information provided in the Sertaconazole Nitrate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Sertaconazole Nitrate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Sertaconazole Nitrate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Sertaconazole Nitrate suppliers with KDMF on PharmaCompass.
A Sertaconazole Nitrate CEP of the European Pharmacopoeia monograph is often referred to as a Sertaconazole Nitrate Certificate of Suitability (COS). The purpose of a Sertaconazole Nitrate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Sertaconazole Nitrate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Sertaconazole Nitrate to their clients by showing that a Sertaconazole Nitrate CEP has been issued for it. The manufacturer submits a Sertaconazole Nitrate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Sertaconazole Nitrate CEP holder for the record. Additionally, the data presented in the Sertaconazole Nitrate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Sertaconazole Nitrate DMF.
A Sertaconazole Nitrate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Sertaconazole Nitrate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Sertaconazole Nitrate suppliers with CEP (COS) on PharmaCompass.
A Sertaconazole Nitrate written confirmation (Sertaconazole Nitrate WC) is an official document issued by a regulatory agency to a Sertaconazole Nitrate manufacturer, verifying that the manufacturing facility of a Sertaconazole Nitrate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Sertaconazole Nitrate APIs or Sertaconazole Nitrate finished pharmaceutical products to another nation, regulatory agencies frequently require a Sertaconazole Nitrate WC (written confirmation) as part of the regulatory process.
click here to find a list of Sertaconazole Nitrate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Sertaconazole Nitrate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Sertaconazole Nitrate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Sertaconazole Nitrate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Sertaconazole Nitrate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Sertaconazole Nitrate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Sertaconazole Nitrate suppliers with NDC on PharmaCompass.
Sertaconazole Nitrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sertaconazole Nitrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sertaconazole Nitrate GMP manufacturer or Sertaconazole Nitrate GMP API supplier for your needs.
A Sertaconazole Nitrate CoA (Certificate of Analysis) is a formal document that attests to Sertaconazole Nitrate's compliance with Sertaconazole Nitrate specifications and serves as a tool for batch-level quality control.
Sertaconazole Nitrate CoA mostly includes findings from lab analyses of a specific batch. For each Sertaconazole Nitrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sertaconazole Nitrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Sertaconazole Nitrate EP), Sertaconazole Nitrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sertaconazole Nitrate USP).
LOOKING FOR A SUPPLIER?